zm 241385 has been researched along with inosine in 2 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (inosine) | Trials (inosine) | Recent Studies (post-2010) (inosine) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 3,722 | 120 | 740 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JJ; Huang, NK; Lai, WL; Lin, YR; Lu, MK | 1 |
| Adam, RM; Chung, YG; Cristofaro, V; Doyle, C; Lukianov, SN; Sack, BS; Schäfer, M; Sullivan, MP | 1 |
2 other study(ies) available for zm 241385 and inosine
| Article | Year |
|---|---|
Adenosine as an active component of Antrodia cinnamomea that prevents rat PC12 cells from serum deprivation-induced apoptosis through the activation of adenosine A(2A) receptors.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Aminohydrolases; Animals; Apoptosis; Culture Media, Serum-Free; Inosine; PC12 Cells; Polyporales; Rats; Triazines; Triazoles | 2006 |
Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A
Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Humans; Inosine; Potassium Channels; Rats; Receptor, Adenosine A2A; Spinal Cord Injuries; Sulfonamides; Triazines; Triazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Xanthines | 2017 |